4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-18-018317
Chief Medical Officer acquired 8,304 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS JOHN C. JR Chief Medical Officer | 2018-06-25 | Conversion | +8,304 | 8,304 | D | ||
| Derivatives | |||||||
| DAVIS JOHN C. JR Chief Medical Officer | 2018-06-25 | Conversion · Series C Preferred Stock | −21,459 | 0 | D | ||
Loading xslF345X03/doc4.xml…